A&O Shearman on life sciences
Our global network of life sciences experts will share their views and insights on the latest developments in the industry. They'll comment on and analyse topics including pharmaceuticals, digital health, medical devices, biotech, IP and life sciences regulatory issues around the world.
Latest blog posts
The European Commission (EC) has published its latest report on competition enforcement in medicines and medical products.
On January 10, 2024, Senators Chris Coons and Thom Tillis introduced a bill titled Improving Efficiency to Increase Competition Act (“IEICA”).
In Germany and the EU, medical devices are subject to a complex and evolving regulatory framework, covering aspects such as safety, performance, clinical evaluation, labelling, post-marketing surveillance and environmental considerations.
The Biden Administration’s recent publication of the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights and its request for comments on the draft guidance will impact how march-in rights under Bayh-Dole may be exercised in the future.
The UK Competition and Markets Authority (CMA) has taken the unusual step of issuing a prioritisation statement on cooperation between competitors to make combination therapies available to the NHS.
Our insights
Explore the views of the world's leading lawyers on the issues that matter for global business.
Explore all of our insights